pI: 6.5467 |
Length (AA): 569 |
MW (Da): 64842 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
162 | 245 | 1na0 (A) | 19 | 105 | 14.00 | 0.000032 | 0.44 | 0.39 | -0.99 |
151 | 219 | 5fzs (A) | 2 | 70 | 19.00 | 0.14 | 0.36 | 0.403965 | -0.75 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128765)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G08190 | vacuolar protein sorting-associated protein 41 |
Brugia malayi | Bm1_34430 | Vacuolar assembly protein VPS41 homolog |
Brugia malayi | Bm1_20740 | hypothetical protein |
Candida albicans | CaO19.4858 | similar to N terminus of protein involved in vacuolar assembly |
Candida albicans | CaO19.4860 | hypothetical protein |
Candida albicans | CaO19.4859 | similar to internal portion of VPS41 protein involved in vacuolar assembly |
Candida albicans | CaO19.12323 | hypothetical protein |
Candida albicans | CaO19.12322 | similar to internal portion of VPS41 protein involved in vacuolar assembly |
Candida albicans | CaO19.12321 | similar to N terminus of protein involved in vacuolar assembly |
Caenorhabditis elegans | CELE_F32A6.3 | Protein VPS-41, isoform B |
Dictyostelium discoideum | DDB_G0286803 | 7-fold repeat in clathrin and VPS proteins repeat-containing protein |
Drosophila melanogaster | Dmel_CG18028 | light |
Echinococcus granulosus | EgrG_000123800 | vacuolar protein sorting associated protein 41 |
Echinococcus multilocularis | EmuJ_000123800 | vacuolar protein sorting associated protein 41 |
Homo sapiens | ENSG00000006715 | vacuolar protein sorting 41 homolog (S. cerevisiae) |
Leishmania braziliensis | LbrM.30.1410 | vacuolar assembly protein vps41, putative |
Leishmania donovani | LdBPK_301350.1 | vacuolar assembly protein vps41, putative |
Leishmania infantum | LinJ.30.1350 | vacuolar assembly protein vps41, putative |
Leishmania major | LmjF.30.1280 | vacuolar assembly protein vps41, putative |
Leishmania mexicana | LmxM.29.1280 | vacuolar assembly protein vps41, putative |
Loa Loa (eye worm) | LOAG_01302 | hypothetical protein |
Loa Loa (eye worm) | LOAG_01303 | hypothetical protein |
Mus musculus | ENSMUSG00000041236 | vacuolar protein sorting 41 (yeast) |
Oryza sativa | 4335134 | Os04g0195000 |
Saccharomyces cerevisiae | YDR080W | Vps41p |
Schistosoma japonicum | Sjp_0077560 | Vacuolar protein sorting-associated protein 41 homolog, putative |
Schistosoma mansoni | Smp_073110 | vacuolar protein sorting vps41 |
Schistosoma mansoni | Smp_073100 | vacuolar protein sorting vps41 |
Schmidtea mediterranea | mk4.001034.01 | |
Trypanosoma brucei gambiense | Tbg972.6.2540 | vacuolar assembly protein vps41, putative |
Trypanosoma brucei | Tb927.6.2770 | Vacuolar assembly protein vps41 |
Trypanosoma congolense | TcIL3000_6_2230 | vacuolar assembly protein vps41, putative |
Trypanosoma congolense | TcIL3000_0_18920 | vacuolar assembly protein vps41, putative |
Trypanosoma cruzi | TcCLB.507923.30 | vacuolar assembly protein vps41, putative |
Trypanosoma cruzi | TcCLB.463359.9 | vacuolar assembly protein vps41, putative |
Trypanosoma cruzi | TcCLB.511753.140 | vacuolar assembly protein vps41, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.6.2770 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.6.2770 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.6.2770 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.6.2770 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F32A6.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F32A6.3 | Caenorhabditis elegans | larval arrest | wormbase |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.